Viewing StudyNCT00000642



Ignite Creation Date: 2024-05-05 @ 11:19 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000642
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G rCD4-IgG in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
Pregnancy
HIV Infections
Keywords:
Name View
Immunization Passive View
Recombinant Proteins View
Pregnancy Trimester Third View
Pregnancy View
Pregnancy Complications Infectious View
IgG View
Drug Evaluation View
Antigens CD4 View
AIDS-Related Complex View